As interest in metabolic resilience grows, tools like bimagrumab create new avenues to protect what matters moststrength, mobility, and function
The most common side effects are rash, diarrhea, low thyroid hormone, and fatigue, but they can also include inflammation of the lung, intestines or liver, hormonal abnormalities, and kidney, heart, or neurologic problems
Regulatory Shifts May Play a Role If the FDA broadens the approved use of GLP-1s or legislation changes how weight-loss drugs are classified for insurance purposes, employer decisions may shift accordingly
10.1023/A:1022095324407
Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV